|
|
|
|
|
|
|
13.07.26 - 22:09
|
Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth (GlobeNewswire EN)
|
|
|
VANCOUVER, British Columbia, July 13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced updates to its executive leadership and operating structure as the Company continues to prepare for its next stage of clinical and commercial development....
|
|
|
13.07.26 - 21:27
|
Novartis erhält Zulassung für Vanrafia in Kanada (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX) - Novartis hat in Kanada eine Zulassung für das Nierenmittel Vanrafia (Atrasentan) in Tablettenform erhalten. Es soll zur Senkung der Proteinurie bei Menschen mit der Nierenerkrankung IgA-Nephropathie ......
|
|
|
|
|
|
|
13.07.26 - 15:15
|
Amonty, Deutsche Bank oder Bayer: Wer überrascht im zweiten Halbjahr? (Sharedeals)
|
|
|
Während sich die internationalen Aktienmärkte auf hohem Niveau bewegen, rücken Einzeltitel mit besonderem Kurspotenzial stärker in den Fokus. Almonty Industries, Deutsche Bank und Bayer stehen dabei für drei völlig unterschiedliche Investmentstorys. Almonty profitiert vom weltweiten Wettbewerb um kritische Rohstoffe und hat mit dem Produktionshochlauf der Sangdong-Mine in Südkorea einen entscheidenden Meilenstein erreicht. Das Unternehmen könnte […]
The post Amonty, Deutsche Bank oder Bayer: Wer überrascht im zweiten Halbjahr? first appeared on sharedeals.de....
|
|
|
13.07.26 - 15:06
|
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026 (Business Wire)
|
|
|
MindWalk to host an earnings conference call and webcastAUSTIN, Texas--(BUSINESS WIRE)--$HYFT #ai--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for the fourth quarter and full fiscal year 2026 and host a conference call on Wednesday, July 22, 2026, at 5:00 p.m. Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session.
Conference Call and Webcast Details
Event Date and Time: Wednesday, July 22, 2026, at 5:00 p.m. Eastern Time
The conference call will be webcast live and available for replay via a link provided in the Events section of the Company's Investor Relations pages at: https://ir.mindwalkai.com/events-and-presentations/default.aspx
Participant Dial-Ins:
USA / International Toll: +1 (646) 307-1963
USA Toll-Free: (800) 715-9871
Canada (Toronto): (647) 932-3411
Canada Toll-Free...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.07.26 - 12:36
|
Cresco Labs to Report Second Quarter 2026 Financial Results on August 6, 2026 (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended June 30th, 2026 on Thursday, August 6, 2026 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
Event: Cresco Labs Second Quarter 2026 Earnings Conference Call
Date: Thursday, August 6, 2026
Time: 8:30 am ET
Webcast: LINK
Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
About Cresco Labs Inc.
Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative ...
|
|